Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA)

A D Smith, C Johnston, E Sim, Z Nagy, K A Jobst, N Hindley, E King

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)
Original languageEnglish
Pages (from-to)473-4
Number of pages2
JournalThe Lancet
Issue number8920
Publication statusPublished - 13 Aug 1994


  • Aged
  • Alzheimer Disease
  • Apolipoprotein E2
  • Apolipoproteins E
  • Case-Control Studies
  • Dementia
  • Gene Frequency
  • Genotype
  • Humans
  • Risk Factors

Cite this